Trial NCT00960531

View at ClinicalTrials.gov 
Org. Study IDs: 3134K1-2205
Secondary IDs: B2571008

Last trial update was posted on 2016-04-01

MeSH Interventions

Saponin QA-21V1

MeSH Conditions

Alzheimer Disease

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

In 2013 the sponsor decided that ACC-001 would not be further developed in mild to moderate Alzheimer's disease, study drug administration was discontinued, and remaining participants were followed for safety for up to 6 months after last injection.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID